Is there a duty to inform patients of phase I trials?
Publication
, Journal Article
Bruce, CR; Flamm, AL; Leblanc, TW; Rosoff, PM
Published in: Virtual Mentor
March 1, 2009
Duke Scholars
Published In
Virtual Mentor
DOI
ISSN
1937-7010
Publication Date
March 1, 2009
Volume
11
Issue
3
Start / End Page
207 / 214
Location
United States
Citation
APA
Chicago
ICMJE
MLA
NLM
Bruce, C. R., Flamm, A. L., Leblanc, T. W., & Rosoff, P. M. (2009). Is there a duty to inform patients of phase I trials? Virtual Mentor, 11(3), 207–214. https://doi.org/10.1001/virtualmentor.2009.11.3.ccas2-0903
Bruce, Courtenay R., Anne Lederman Flamm, Thomas W. Leblanc, and Philip M. Rosoff. “Is there a duty to inform patients of phase I trials?” Virtual Mentor 11, no. 3 (March 1, 2009): 207–14. https://doi.org/10.1001/virtualmentor.2009.11.3.ccas2-0903.
Bruce CR, Flamm AL, Leblanc TW, Rosoff PM. Is there a duty to inform patients of phase I trials? Virtual Mentor. 2009 Mar 1;11(3):207–14.
Bruce, Courtenay R., et al. “Is there a duty to inform patients of phase I trials?” Virtual Mentor, vol. 11, no. 3, Mar. 2009, pp. 207–14. Pubmed, doi:10.1001/virtualmentor.2009.11.3.ccas2-0903.
Bruce CR, Flamm AL, Leblanc TW, Rosoff PM. Is there a duty to inform patients of phase I trials? Virtual Mentor. 2009 Mar 1;11(3):207–214.
Published In
Virtual Mentor
DOI
ISSN
1937-7010
Publication Date
March 1, 2009
Volume
11
Issue
3
Start / End Page
207 / 214
Location
United States